Overview

GT Biosciences is a techbio company developing scalable cell-type-specific precision therapies. The company is building Deliveromics, a spatial biology and AI-powered platform for high-throughput in vivo screening and predictive design of targeted delivery vehicles such as ligand-conjugated lipid nanoparticles. We are creating cell-type-specific delivery solutions for the brain, immune system, and other tissues.